ANI Pharmaceuticals Inc (ANIP)
Payables turnover
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Cost of revenue | US$ in thousands | 250,210 | 181,513 | 138,785 | 100,610 | 87,157 |
Payables | US$ in thousands | — | — | — | — | — |
Payables turnover | — | — | — | — | — |
December 31, 2024 calculation
Payables turnover = Cost of revenue ÷ Payables
= $250,210K ÷ $—K
= —
The payables turnover ratio for ANI Pharmaceuticals Inc is not available for the years ending December 31, 2020, 2021, 2022, 2023, and 2024. The payables turnover ratio is a key indicator of how efficiently a company is managing its accounts payable. Without this information, it is challenging to assess the company's ability to pay its suppliers and manage its working capital effectively. It is important for investors and analysts to have access to this ratio to evaluate ANI Pharmaceuticals Inc's financial performance comprehensively.
Peer comparison
Dec 31, 2024
Company name
Symbol
Payables turnover
ANI Pharmaceuticals Inc
ANIP
—
Abbott Laboratories
ABT
—
AbbVie Inc
ABBV
—
ACADIA Pharmaceuticals Inc
ACAD
—
Alkermes Plc
ALKS
19.54
Amphastar P
AMPH
11.74
Arcus Biosciences Inc
RCUS
8.33
Biomarin Pharmaceutical Inc
BMRN
—
Bristol-Myers Squibb Company
BMY
8.82
Catalyst Pharmaceuticals Inc
CPRX
—
Collegium Pharmaceutical Inc
COLL
—